Emergence Global Enterprises Inc. Announces Q3 Earnings & Financial Statements

Revenue Increased by 205% from Q2 2021

WINDSOR, ONTARIO, CANADA, September 28, 2021 /EINPresswire.com/ — Emergence Global Enterprises Inc. (“Emergence Global” or the “Company”) (CSE: EMRG) (OTCQB: ELOAF), an acquirer, creator, and builder of reputable natural health consumer foods, products, and brands, is pleased to announce Q3 revenue of $685K USD for the period from May 1, 2021, to July 31, 2021. Revenue for the first three quarters of fiscal 2021 stands at $1.1 M USD. Net Income improved to a net loss of $78K USD compared to the previous period.

“Emergence Global and its associated brands continue to improve its sales channels and increase its revenue from $224 K USD in Q2 to $685K USD in Q3,” said Joseph Byrne, Chair of the Board and President & Chief Executive Officer of Emergence Global Enterprises Inc.

“Emergence continues to execute its business plan and provide continued value for our customers, employees, and shareholders,” Byrne noted. Emergence continues to integrate these new operations and recently completed the initial implementation of Oracle’s NetSuite ERP System to drive efficiency and growth.

The Company recently held its 2020 Annual General Meeting in Windsor, Ontario, and is pleased to announce that all resolutions presented by the Company were ratified by the shareholders, including the appointment of Directors and Audit Firm, along with the adoption of the 2021 Fixed Stock Option Plan.

Additional information about the Company can be found on SEDAR under the Issuer Profile of “Emergence Global Enterprises Inc.” or on OTC MARKETS.

About the Company
Emergence Global Enterprises Inc. (“Emergence”) is an acquirer, creator, and builder of reputable natural health consumer foods, products, and brands. Following the acquisition of Nubreed Nutrition, Inc., Emergence has become a North American developer and distributor of branded sports and nutrition specialty supplements. The Company is currently considering several development projects.
For further information on the Company, please contact:

Joseph Byrne, President & Chief Executive Officer / Director
Phone: 519-257-0460
Email: joe@emergenceglobalinc.com

Shawn Balaghi, Investor Relations
Phone: 604-773-0242
Email: ir@emergenceglobalinc.com

Cautionary Statement Regarding Forward-Looking Information
Forward-Looking Statements

This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to closing and the terms and conditions of the proposed transaction; the business and operations of the Company after closing the proposed transaction. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties; delay or failure to receive board, shareholder, or regulatory approvals; and the uncertainties surrounding the nutraceutical and botanical industry. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. There can be no assurance that the proposed transaction will occur or that the anticipated financial, economic, or strategic benefits will be realized.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) or OTC Markets accepts responsibility for the adequacy or accuracy of this press release.

Brian S. Payne
Emergence Global Enterprises Inc.
+1 519-981-0970
email us here
Visit us on social media:
Twitter

Leave a Reply

Your email address will not be published. Required fields are marked *